Fig. 5.
The maximum changes in MAP after intravenous injection of arecoline. (A) Dose-dependent increases in MDMAP; (B) dose-dependent increases in MIMAP. MDMAP: maximum decreased MAP; MIMAP: maximum increased MAP. **P < 0.01.
The maximum changes in MAP after intravenous injection of arecoline. (A) Dose-dependent increases in MDMAP; (B) dose-dependent increases in MIMAP. MDMAP: maximum decreased MAP; MIMAP: maximum increased MAP. **P < 0.01.